Clinical Trial Update: Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 trial evaluating the efficacy and safety of Eplivanserin 5 mg daily for sleep maintenance insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Eplivanserin (Eplivanserin)

Snippet

Sponsor: Sanofi | Conditions: Sleep Initiation and Maintenance Disorders, Insomnia | Phase 3 | Status: COMPLETED